Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy.

OBJECTIVE To prevent perinatal transmission of hepatitis B virus (HBV), WHO recommends that the first dose of hepatitis B (HepB) vaccine be given within 24 hours after birth. This presents a challenge in remote areas with limited cold-chain infrastructure and where many children are born at home. METHODS Rural townships in three counties in China's Hunan Province were randomized into three groups with different strategies for delivery of the first dose of HepB vaccine. In group 1, vaccine was stored within the cold chain and administered in township hospitals. In group 2, vaccine was stored out of the cold chain in villages and administered by village-based health workers to infants at home. Group 3 used the same strategy as group 2, but vaccine was packaged in a prefilled injection device. Training of immunization providers and public communication conveying the importance of the birth dose was performed for all groups. FINDINGS Among children born at home, timely administration (within 24 hours after birth) of the first dose of HepB vaccine increased in all groups after the study: group 1, from 2.4% to 25.2%; group 2, from 2.6% to 51.8%; and group 3, from 0.6% to 66.7%; P < 0.001 in each case. No significant difference in antibody response to vaccine was observed between the groups. CONCLUSION Timely administration of the first dose of HepB vaccine was improved by communication and training activities, and by out-of-cold-chain storage of vaccine and administration at the village level, especially among children born at home.

[1]  H. Long,et al.  Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam. , 2006, The American journal of tropical medicine and hygiene.

[2]  B. Biggs,et al.  Improving birth dose coverage of hepatitis B vaccine. , 2006, Bulletin of the World Health Organization.

[3]  Fangjun Zhou,et al.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.

[4]  H. Wibisono,et al.  Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. , 2004, Bulletin of the World Health Organization.

[5]  B. Otto,et al.  At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain. , 1999, Vaccine.

[6]  Y. Barenholz,et al.  Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. , 1999, Vaccine.

[7]  A. Sutanto,et al.  Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. , 1999, Bulletin of the World Health Organization.

[8]  Munn Sann Lye,et al.  Evaluation of cold chain monitoring in Kelantan, Malaysia. , 1996, Bulletin of the World Health Organization.

[9]  S. Marion,et al.  Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. , 1994, American journal of epidemiology.

[10]  N. Miller,et al.  Are childhood immunization programmes in Australia at risk? Investigation of the cold chain in the Northern Territory. , 1994, Bulletin of the World Health Organization.

[11]  J. Hoofnagle,et al.  Viral hepatitis and liver disease , 1984 .

[12]  R. Henderson,et al.  Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. , 1982, Bulletin of the World Health Organization.

[13]  P. L. White,et al.  National nutrition survey. , 1973, JAMA.